Novartis sees profit slip
October 23, 2013Sales and Marketing Afinitor, Diovan, Novartis, Q3, gilenya
Novartis saw generic competition erode profit in the third quarter of the year, although sales across the group actually rose …
Sanofi launches ‘Monster Manor’ diabetes app
October 23, 2013Medical Communications Gamification, Sanofi, diabetes, monster manor
Sanofi has launched a new healthcare app called Monster Manor to help children with type 1 diabetes better manage their …
Indian pharma exports ‘set for 20% growth’ to 2018
October 23, 2013Manufacturing and Production API, CPhI, GMP, India, growth
Representatives of India’s pharma sector pledged to meet the government’s target of raising exports to $25 billion by 2016, as …
Reckitt Benckiser may shed pharma unit
October 23, 2013Sales and Marketing Reckitt Benckiser Pharmaceuticals, rbp, suboxone
Reckitt Benckiser Pharmaceuticals is considering selling its pharma unit within the next year after the recent loss of its biggest …
HGS founders join IMS Health team
October 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane
Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team.
NICE ‘yes’ for Jetrea
October 23, 2013Sales and Marketing Jetrea, NHS, NICE, eye
Jetrea has completed its seemingly inexorable journey to NHS use in England and Wales for a rare eye condition following …
AZ begins late-stage trial of new cancer drug
October 22, 2013Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib
AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …
US regulator ponders Arzerra
October 22, 2013Sales and Marketing Arzerra, CLL, FDA, GSK
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the FDA as a first-line treatment for chronic lymphocytic …
Former GSK director joins Publicis Life Brands Resolute
October 22, 2013Manufacturing and Production, Research and Development, Sales and Marketing GSK, PLBR, publicis
Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …
Opsumit wins US approval
October 22, 2013Sales and Marketing actelion fda, opsumit
The FDA has approved Actelion’s oral endothelin receptor antagonist Opsumit as a treatment for pulmonary arterial hypertension (PAH), a potentially …
Effectively outsourcing medical and laboratory equipment procurement
October 21, 2013With Investigator Sites located across the World it is increasingly important to ensure that they all have the right equipment …
Ariad ditches CML trial
October 21, 2013Research and Development, Sales and Marketing Ariad, CML, iclusig
Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …
Eisai: reform NICE or we’ll pull out of the UK
October 21, 2013Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE
Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …
No closer to Alzheimer’s cure despite rise in research
October 21, 2013Research and Development, Sales and Marketing Alzheimer's, depression, markram
A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …
The new paradigm in oncology drug marketing
October 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology
Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …
Mylan hires president of European business
October 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka
Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …
Dust settles on US shutdown
October 21, 2013Medical Communications, Sales and Marketing FDA, Obamacare, PhRMA, shutdown
The FDA has said that it was able to carry out a significant part of its remit during the suspension …
MHRA recalls five Wockhardt medicines
October 18, 2013Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall
The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …
Shire slated following Adderall T-shirt controversy
October 18, 2013Medical Communications, Sales and Marketing Adderall, EMA, FDA, Shire
A senior doctor and patient welfare advocate has criticised Shire after T-shirts emblazoned with the word ‘Adderall’ appeared for sale …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
